News | December 21, 2024
Merck closes license agreement for LM-299
Merck will record a pre-tax charge relating to the upfront payment of $588 million
Merck will record a pre-tax charge relating to the upfront payment of $588 million
SPARC to receive 55% equity in Tiller Therapeutics
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
Esketamine hydrochloride is a vital drug to be used for treating mental illness and is likely to significantly impact the LATAM market
Aster DM Healthcare and Quality Care India Limited have signed definitive agreements to merge, subject to regulatory, corporate and shareholders’ approvals
The first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL
Dr. Muthu was last associated with Mankind Pharma
Emcure has launched an awareness campaign to help spread the word about male anemia
Subscribe To Our Newsletter & Stay Updated
